Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy

Clinical trial NCT01649765 · COMPLETED

Trial details

NCT number: NCT01649765
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2012-09-07
Primary completion: 2018-01-24
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.